Determining joint inventorship: antibody paying attention?
Katherine Tassmer and Todd Garabedian's article, "Determining joint inventorship: antibody paying attention?" for The Patent Lawyer Magazine Annual 2021 issue. Their article discusses the tenets of joint inventorship under U.S. law with specific reference to the Dana-Farber decision.
Katherine is an attorney in Cantor Colburn's Litigation Practice; she assists with an array of patent and trademark litigation matters, including pharmaceutical litigation under the Hatch-Waxman Act. Todd is a Partner and Vice Chair of the firm's Life Sciences Practice Group. He has extensive experience as an intellectual property attorney in a wide variety of disciplines related to the biological and chemical sciences, including chemistry, biochemistry, organic chemistry, pharmaceuticals, molecular biology, and materials science. He has a Ph.D. in Biochemistry.